Dr. Javier Hernandez Losa explains how combining broad genom... Deepak Tripathi, PhD
Read More From tumor heterogeneity to low-frequency variants: How qPCR, dPCR, and NGS work together in cancer research

Dr. Javier Hernandez Losa explains how combining broad genom... Deepak Tripathi, PhD by / 09.26.2026
Read More From tumor heterogeneity to low-frequency variants: How qPCR, dPCR, and NGS work together in cancer research
What happens when a multiplex qPCR assay begins to lose perf... by Behind The Bench Staff / 04.01.2026
Read More Optimizing multiplex qPCR: How to amplify up to 6 targets without compromising analytical sensitivity
Scientific, joins the Absolute Gene-ius podcast to discuss h... Jordan Ruggieri, MBA by / 03.24.2026
Read More From Discovery to Monitoring: How Sequencing and PCR Work Together in Oncology Research
Cancer research is continually evolving, and patient-derived... by Behind The Bench Staff / 10.28.2025
Read More Advancing Cancer Cell-Based Assays with Assay-Ready Tumoroids
Conversation with Dr. Christopher Mason from Weill Cornell M... by Behind The Bench Staff / 07.31.2025
Read More From Telomeres in Space, Cancer Research to Microbes on Earth: Harnessing the Power of qPCR
mRNA therapeutics have delivered on the promise of simple an... by Behind The Bench Staff / 04.16.2025
Read More How to Achieve More Sustainable mRNA Synthesis and Purification
Cancer organoids are 3D cell cultures derived from patient t... by Behind The Bench Staff / 03.04.2025
Read More Effective Techniques for Cancer Organoid Culture
Top FAQs with cancer researchers Our recent webinar—featur... by Behind The Bench Staff / 02.14.2024
Read More Liquid Biopsy Advances in Lung Cancer and Glioblastoma Research: Key Webinar Takeaways
New genetic analysis technologies may enable earlier detecti... by Behind The Bench Staff / 08.11.2023
Read More Could Increased Access to Liquid Biopsy Lead to Earlier Cancer Detection?
Genetic analysis has ushered in a new era for non-small cell... by Behind The Bench Staff / 06.16.2023
Read More Targeting Genetic Alterations in Lung Cancer Continues to Improve Patient Outcomes